Medtronic (MDT) Stock Price, Quote, News & History | Benzinga

SPY778.82+0.03%QQQ751.58+0.04%BTC/USD82,501.10+0.99%DIA516.40+0.06%GLD384.31−0.07%TLT77.97−0.01%

Medtronic PLC (MDT) Stock Price, Quote, News & History

MDTNYSE

Trade with Public

Trade with Public

$88.48

0.730.83%

Last update: Oct 9, 5:09 PM

$88.58

0.830.95%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$88.49

Close

$88.48

Volume / Avg.

38.86M / 12.83M

Day Range

$87.40 - $89.81

52 Wk Range

73.31 - 106.33

Market Cap

$113.38B

P/E Ratio

21.61

Dividend Yield

3.28%

Exchange

NYSE

RSI

49

Short Interest

1.35%

Days to Cover

1.97

Recent Medtronic PLC News

Jim Cramer Doesn’t Like This Health Care Stock, Sees No Reason To Buy Rambus

Cramer dislikes Rambus and MiniMed, calls GigaCloud highly speculative, sees Babcock & Wilcox as a small bet, and favors ADM and Deere.

Avi Kapoor

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Analysts review high-yield healthcare stocks CVS, Medtronic and GSK, offering dividend yields of 3.02%-3.86% and varied ratings.

Avi Kapoor

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields

Analysts review high-yield healthcare stocks CVS, Viatris and Medtronic, citing ratings, price targets, dividend yields and recent company news.

Avi Kapoor

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Analyst ratings and news for high-yield healthcare stocks Medtronic (3.06%), Smith & Nephew (2.74%) and GSK (3.65%).

Avi Kapoor

Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection

MDT shares rise after Q1 beat and raised FY27 growth guidance. Analysts maintain Buy/Outperform ratings, citing broad-based strength.

Priya Nigam

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

8.04B

Investing Cash Flow (TTM)

-3.83B

Financing Cash Flow (TTM)

-3.71B

Free Cash Flow (TTM)

6.13B

Capital Expenditure (TTM)

-1.90B

Net Change in Cash (TTM)

489.00M

Analyst Trends and Forecast

3

Jul

3

Aug

7

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$131.58B

PE Ratio (TTM)

21.61

PE Ratio (FWD)

14.66

PEG Ratio (TTM)

1.58

PS Ratio (TTM)

3.01

PB Ratio (TTM)

2.23

Earnings Yield % (TTM)

4.63%

Earnings Yield % (FWD)

6.82%

EV / EBITDA (TTM)

12.82

Price / EBITDA (TTM)

11.00

Price / Free Cash Flow (TTM)

18.43

Book Value / Share

$39.27

Company Debt

Total Debt

$28.15B

LT Debt

$25.62B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$1.77B

Total Cash

$1.69B

Debt to Equity

0.56

Issuance of Debt (TTM)

-$21.00M

Repayment of Debt (TTM)

-$1.77B